COYA THERAPEUTICS INC (COYA:NASDAQ)
$4.56 -0.28 (-5.7851%)
Analysed COYA THERAPEUTICS INC (COYA:NASDAQ) News Sources
Coya Therapeutics Details ALS Combo Immunotherapy Plan, Highlights Early Biomarker Signals in Webinar
17-02-2026
marketbeat.com
Coya Therapeutics, Inc. (COYA) Upgraded to Buy: What Does It Mean for the Stock?
25-02-2026
yahoo.com
NanoViricides’ Measles Treatment Granted Orphan Drug Designation by FDA
06-05-2026
yahoo.com
NanoViricides to Participate at D. Boral Capital Global Conference in NYC
07-05-2026
yahoo.com
Hantavirus Outbreak Shows Need for Broad-Spectrum Antiviral Drugs
12-05-2026
yahoo.com
Coya Therapeutics secures FDA fast track status for COYA 302
14-05-2026
pharmaceutical-technology.com
Coya Therapeutics Announces the First Cohort of Patients in the ALSTARS Trial Have Begun the Blinded Active-Treatment Extension Phase
08-06-2026
yahoo.com
Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease
15-06-2026
yahoo.com
Coya Therapeutics to Present ALSTARS Trial Design at the ENCALS 2026 Meeting
18-06-2026
yahoo.com
Is Coya Therapeutics, Inc. (COYA) Stock Outpacing Its Medical Peers This Year?
30-06-2026
yahoo.com
What is the current price of COYA THERAPEUTICS INC (COYA:NASDAQ)?
The current price of COYA THERAPEUTICS INC (COYA:NASDAQ) is $4.56.
COYA THERAPEUTICS INC (COYA:NASDAQ) absolute price change since previous trading day?
The absolute price change of COYA THERAPEUTICS INC (COYA:NASDAQ) since the previous trading day is $-0.28.
COYA THERAPEUTICS INC (COYA:NASDAQ) percentage price change since previous trading day?
The percentage price change of COYA THERAPEUTICS INC (COYA:NASDAQ) since the previous trading day is -5.7851%.
What is the most recent average sentiment score for COYA THERAPEUTICS INC (COYA:NASDAQ)?
The most recent average sentiment score for COYA THERAPEUTICS INC (COYA:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for COYA THERAPEUTICS INC (COYA:NASDAQ)?
The most recent sentiment for COYA THERAPEUTICS INC (COYA:NASDAQ) is .
SEC-8K** Filing Available For COYA THERAPEUTICS INC (COYA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.